• Emerging Cell Therapies for Blood Cancers with Arcellx CMO, Chris Heery, MD

  • 2024/09/05
  • 再生時間： 30 分
  • ポッドキャスト

Emerging Cell Therapies for Blood Cancers with Arcellx CMO, Chris Heery, MD

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • In this podcast episode, we sit down with Christopher Heery, the Chief Medical Officer at Arcellx to learn about the company's pipeline and lead cell therapy, anitocabtagene autoleucel, or anito-cel, that is in development for multiple myeloma. Multiple myeloma, like lymphoma and leukemia are types of cancer that start in your blood cells.
    続きを読む 一部表示

あらすじ・解説

In this podcast episode, we sit down with Christopher Heery, the Chief Medical Officer at Arcellx to learn about the company's pipeline and lead cell therapy, anitocabtagene autoleucel, or anito-cel, that is in development for multiple myeloma. Multiple myeloma, like lymphoma and leukemia are types of cancer that start in your blood cells.
経済学
続きを読む 一部表示

Emerging Cell Therapies for Blood Cancers with Arcellx CMO, Chris Heery, MDに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。